SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Orchid Chemicals & Pharmaceuticals informs about Outcome of Board Meeting

01 Apr 2014 Evaluate

Orchid Chemicals & Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on March 31, 2014, have fixed the accounting period for the financial year 2013-14 for a period of 12 Months from October 01, 2013 to September 30, 2014.

The above information is a part of company’s filings submitted to BSE.

 

 

Orchid Pharma Share Price

565.60 12.75 (2.31%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×